Get started
Author

Ulrich Rodeck

Observed names: Rodeck, U., U Rodeck, U. RODECK, U. Rodeck, ULRICH RODECK, Ulrich Rodek, Ulrich. Rodeck
Observed institutions: The Wistar Institute, Tufts University, The University of Texas MD Anderson Cancer Center, University of Miami, Thomas Jefferson University, The University of Texas at San Antonio Health Science Center, German Cancer Research Center, Thomas Jefferson University Hospital, Hospital of the University of Pennsylvania, Sidney Kimmel Cancer Center, University Medical Center Hamburg-Eppendorf, Dana-Farber Cancer Institute, Essen University Hospital, Sylvester Comprehensive Cancer Center, University of Turin, Drexel University, University of Pennsylvania, Temple University
ORCID: 0000-0002-0174-6125
Observed ORCID: 0000-0002-0174-6125
OpenAlex ID: A5047513658
Zebrafish: An Emerging Model System for Human Disease and Drug Discovery
2007 · G Kari, U Rodeck, et al. · Clinical Pharmacology & Therapeutics · 467
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis
2019 · Dan A. Erkes, Weijia Cai, et al. · Cancer Discovery · 456
PDF
The EGF receptor - an essential regulator of multiple epidermal functions.
2000 · M Jost, C Kari, et al. · PubMed · 298
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
1995 · H D Menssen, H J Renkl, et al. · PubMed · 260
Regulation of NK cell functions by TGF-β 1
1995 · G Bellone, M Aste-Amezaga, et al. · The Journal of Immunology · 243
Biology of tumor progression in human melanocytes.
1987 · M Herlyn, W H Clark, et al. · PubMed · 234
Tumor-Associated Transforming Growth Factor-β and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients
1999 · Graziella Bellone, Anna Turletti, et al. · American Journal Of Pathology · 227
PDF
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
1995 · K M Amin, L A Litzky, et al. · PubMed · 197
Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma
1999 · Kai Ge, James DuHadaway, et al. · Proceedings of the National Academy of Sciences · 196
PDF
Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors.
1986 · E M Rakowicz-Szulczynska, U Rodeck, et al. · Proceedings of the National Academy of Sciences · 190
Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor.
1986 · B Westermark, A Johnsson, et al. · Proceedings of the National Academy of Sciences · 182
Transforming Growth Factor β Enhances Epithelial Cell Survival via Akt-dependent Regulation of FKHRL1
2001 · Incheol Shin, Andrei V. Bakin, et al. · Molecular Biology of the Cell · 178
In vivo Radioprotection by the Fullerene Nanoparticle DF-1 as Assessed in a Zebrafish Model
2006 · Borbala Daroczi, Gabor Kari, et al. · Clinical Cancer Research · 175
Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes
1991 · Ulrich Rodeck, Karl Melber, et al. · Journal of Investigative Dermatology · 171
Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage.
2003 · Csaba Kari, Tung O Chan, et al. · PubMed · 170
EGF-R dependent regulation of keratinocyte survival
1997 · Ulrich Rodeck, Monika Jost, et al. · Journal of Cell Science · 164
Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway
2001 · Monika Jost, Teresa M. Huggett, et al. · Journal of Biological Chemistry · 160
Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide
1987 · Uma Murthy, Aruna Basu, et al. · Archives of Biochemistry and Biophysics · 158
Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.
1987 · U Rodeck, M Herlyn, et al. · PubMed · 150
Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit
2002 · Tung O. Chan, Ulrich Rodeck, et al. · Cancer Cell · 146
PDF
Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors
1987 · Ulrich Rodeck, Meenhard Herlyn, et al. · International Journal of Cancer · 143
Regulation of intracellular pH in human melanoma: potential therapeutic implications.
2002 · Miriam L Wahl, Judith A Owen, et al. · PubMed · 141
Cooperative Induction of a Tolerogenic Dendritic Cell Phenotype by Cytokines Secreted by Pancreatic Carcinoma Cells
2006 · Graziella Bellone, Anna Carbone, et al. · The Journal of Immunology · 136
PDF
Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
2019 · Ayan Tyagi Kumar, Alexander Knops, et al. · Frontiers in Oncology · 134
PDF
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress
2018 · John C. Flickinger, Ulrich Rodeck, et al. · Vaccines · 133
PDF
Works count: 266
Citation count: 11,060
H-index: 59
I10-index: 139
Year
Topic
Type